Apo-Lamivudine-Zidovudine 150 mg

APO-LAMIVUDINE-ZIDOVUDINE 150 MG tablets combine lamivudine and zidovudine for HIV treatment. This oral medication is designed to manage HIV infection as part of a comprehensive treatment plan.

APO-LAMIVUDINE-ZIDOVUDINE 150 MG tablets are used in the treatment of HIV infection. This combination medication helps to control the virus and improve immune function. It is typically prescribed as part of a broader antiretroviral therapy regimen to manage HIV and reduce the risk of disease progression.

Common effects of APO-LAMIVUDINE-ZIDOVUDINE 150 MG tablets may include fatigue, headache, and nausea. Some individuals might experience changes in appetite or mild gastrointestinal discomfort. These effects vary and are not experienced by everyone.

APO-LAMIVUDINE-ZIDOVUDINE 150 MG tablets should be handled with care. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Regular monitoring may be necessary to assess treatment effectiveness and side effects.

APO-LAMIVUDINE-ZIDOVUDINE 150 MG tablets may interact with other medications, including certain antiretrovirals and drugs metabolized by the liver. Alcohol and other substances that affect liver function should be avoided. Always inform your healthcare provider about all medications you are taking.